Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 801 results for "hodgkin"

Patients With Hodgkin Lymphoma May Benefit From PET-CT Scans t...

Share this content: Patients with advanced Hodgkin lymphoma may benefit from positron-emission tomography-computed tomography (PET-CT) testing. Patients with advanced Hodgkin lymphoma may benefit from positron-emission tomography-computed ... Cancer Therapy Advisor, 3 days ago
Fine-Tuning the Treatment of Hodgkin's Lymphoma New England Journal of Medicine, 4 days ago
[x]  

120 images for hodgkin

FOXNews.com, 2 hours ago
Veterinary Economics, 3 days ago
University of Southampton, 2 days ago
Caringbridge.org, 1 week ago
MyNewsDesk, 1 week ago
lymphomanewstoday.com, 5 days ago
KTXS-TV, 5 days ago
wcvb.com, 5 days ago
wcvb.com, 5 days ago
Zacks.com, 6 days ago

Scans May Spare Some Hodgkin Lymphoma Patients From Chemo

(HealthDay News) -- A certain type of medical scan can be used to help spare some Hodgkin lymphoma patients from the severe side effects of chemotherapy, a new study suggests. Researchers found that PET imaging can identify patients whose Hodgkin ...
 US News & World Report4 days ago Scans May Spare These Patients From Chemo  WebMD4 days ago
[x]  
WCVB.com

NFL notebook: Chiefs' Berry named Halas Award winner

Kansas City Chiefs safety Eric Berry, who overcame a diagnosis of Hodgkin lymphoma in late 2014 to return to the field and have an All-NFL season in 2015, has been selected as the 2016 George Halas Award winner by the Professional Football Writers ...
 WCVB.com6 days ago Kansas City Chiefs' Eric Berry wins Halas Award  UPI6 days ago PFWA names Chiefs S Eric Berry recipient of George Halas Award  Equilibrio Informativo6 days ago
BBC

Adrian Munday death: Stuart Hodgkin jailed for life for murder

14 June 2016 From the section Devon Image copyright Devon and Cornwall Police Image caption Adrian Munday's body was found at his house in Devon A man has been jailed for life for murdering and setting fire to a vulnerable person in a ...
 BBC1 week ago Man jailed for killing 'vulnerable' man  BBC1 week ago CCTV shows how murderer stole from vulnerable man  ITV.com1 week ago Homeless man jailed for life for murdering 'gentle giant'  ITV.com1 week ago

New Data on Bristol-Myers Squibb's Opdivo nivolumab Indicate Benefit in Heavily Pre-Treated Classical Hodgkin Lymphoma Patients in Phase 2,...

New Data on Bristol-Myers Squibb's Opdivo nivolumab Indicate Benefit in Heavily Pre-Treated Classical Hodgkin Lymphoma Patients in Phase 2, Single-Arm Pivotal Trial By a News Reporter-Staff News Editor at Biotech Week Bristol-Myers Squibb Company ...
 Pharmacy Choice5 days ago BMS reports encouraging results from Phase II classical Hodgkin lymphoma trial  PredictWallStreet6 days ago BMY On The CheckMate Tear: Updated Results In Hodgkin Lympoma For Opdivo  Seeking Alpha1 week ago ONO PHARMACEUTICAL : New Data on Opdivo (nivolumab) Indicate Benefit in Heavily Pre-Treated Classical Hodgkin Lymphoma Patients in Phase 2, Single-Arm Pivotal Trial (167KB)  4 Traders1 week ago
[x]  
FierceBiotech

Bay State Biotech Report: Infinity Restructuring

Infinity Pharmaceuticals has announced it's restructuring after disappointing Phase 2 study of its treatment for non-Hodgkin lymphoma. That's on the Bay State Biotech Report, where Bloomberg biotechnology reporter Doni Bloomfield and Boston radio ...
 Bloomberg1 week ago Infinity Pharma back under a cloud after duvelisib disappoints in PhII  FierceBiotech1 week ago

Augusta's Hodgkins housing project more than half finished [Kennebec Journal, Augusta, Maine]

June 12--AUGUSTA -- The former Hodgkins Middle School may be undergoing a massive renovation, turning the 1958 school building into affordable apartments for senior citizens; but much of it, other than the old classrooms that are becoming new ...
 Bloomberg2 weeks ago Officials, experts tout Augusta's potential for housing development [Kennebec Journal, Augusta, Maine]  Bloomberg5 days ago
LymphomaNewsToday.com

Epizyme, Genentech Join Forces for Tazemetostat and Tecentriq Trial in Non-Hodgkin Lymphoma

Life Sciences Jobs
 BioSpace4 days ago Epizyme Initiates Collaboration on Combination Trial of Tazemetostat and Tecentriq (atezolizumab) for Treatment of Non-Hodgkin Lymphoma  Stockwatch5 days ago Epizyme Presents Positive Clinical Data on Tazemetostat in Relapsed or Refractory Non-Hodgkin's Lymphoma  LymphomaNewsToday.com5 days ago Non-Hodgkin's Lymphoma, Farmers and the Use of Glyphosate: What You Should Know  LymphomaNewsToday.com6 days ago
[x]  
Zacks.com

Epizyme nabs combo trial deal with Genentech for NHL candidate

Early this week, Wall Street dinged Epizyme on concerns that Phase II data for its non-Hodgkin lymphoma candidate tazemetostat didn't live up to the expectations set by prior testing. But now the biotech nabbed a partner in Roche's Genentech ($ROG) ...
 FierceBiotech4 days ago Epizyme Offers Early Data on Non-Hodgkin Lymphoma Drug  Zacks.com6 days ago
[x]  

Rich Pharmaceuticals Retains Theradex Systems To Help Advance Its Hodgkin's Lymphoma Indication

/PRNewswire/ -- Rich Pharmaceuticals, Inc. (OTCPK:RCHA) ("Rich" or the "Company"), announced today it has entered into an additional agreement with Theradex Systems, Inc. ("Theradex"), a leading global Contract Research Organization ("CRO"), to ...
 Nasdaq6 days ago Rich Pharma Retains Theradex Systems To Help Advance Its Hodgkin's Lymphoma Indication  BioSpace6 days ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - hodgkin
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less